Miragen Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.1M | 49k | 22.75 |
| 2024-06-30 | $487k | 38k | 13.01 |
| 2024-03-31 | $563k | 32k | 17.51 |
| 2023-12-31 | $564k | 26k | 21.78 |
| 2023-09-30 | $1.1M | 72k | 15.34 |
| 2023-06-30 | $1.6M | 69k | 23.79 |
| 2022-09-30 | $16k | 808 | 20.27 |
| 2022-06-30 | $7.0k | 614 | 11.40 |
| 2022-03-31 | $5.1k | 311 | 16.39 |
| 2021-12-31 | $8.0k | 486 | 16.53 |
| 2021-09-30 | $8.8k | 412 | 21.28 |
| 2021-06-30 | $10k | 519 | 19.61 |
| 2021-03-31 | $8.4k | 490 | 17.09 |